PDF format
JBR-2019-0090-supplementary Download(715KB)JBR-2019-0090-supplementary
Figures of the Article
Related articles
-
2024, 38(2): 122-136. DOI: 10.7555/JBR.37.20220220
-
2023, 37(3): 153-165. DOI: 10.7555/JBR.36.20220105
-
2022, 36(2): 98-108. DOI: 10.7555/JBR.36.20220001
-
2018, 32(6): 434-441. DOI: 10.7555/JBR.32.20170117
-
Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
-
2018, 32(6): 389-400. DOI: 10.7555/JBR.32.20180045
-
2018, 32(2): 145-156. DOI: 10.7555/JBR.31.20170039
-
2017, 31(6): 559-562. DOI: 10.7555/JBR.31.20160119
-
2016, 30(6): 502-509. DOI: 10.7555/JBR.30.20160061
-
2013, 27(4): 291-295. DOI: 10.7555/JBR.27.20120143